The effect of HBXIP on NSCLC cell growth was assessed using a MTS assay, which showed that HBXIP knockdown significantly decreased the growth of both the A549 and H1299 cell lines (Figure 2A, 2C). Here, LAMTOR5 is linked to non-small cell lung carcinoma.